Pulmonary Nocardiosis — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — IV then oral Co-trimoxazole (high dose: 15 mg/kg/day of trimethoprim component initially) for 6–12 months
Nocardiosis in immunosuppressed patients (Methotrexate) presents as pulmonary disease mimicking TB or malignancy. Nocardia is partially acid-fast (distinguishing it from Actinomyces) and aerobic. Co-trimoxazole is first-line treatment at high dose (Trimethoprim component 15 mg/kg/day initially). Treatment duration is prolonged: 6–12 months for pulmonary disease, and longer for CNS involvement. Brain imaging should be performed even in asymptomatic patients as CNS dissemination occurs in ~30% of cases. Alternatives include Carbapenems, Amikacin, and Linezolid.
Reference: BSAC 2022 – Nocardiosis; BTS 2023 – Pulmonary nocardiosis